Brief: Grifols - Board has approved IPO on U.S. stock market of a portion of shares of Grifols’ U.S. Biopharma Business

Grifols

24/03/2026 21:10

March 24 (Reuters) - Grifols SA GRLS.MC:

GRIFOLS - IF THE TRANSACTION IS SUCCESSFULLY COMPLETED, GRIFOLS WOULD FLOAT A MINORITY STAKE IN GRIFOLS' BIOPHARMA U.S.

GRIFOLS - THE PARENT COMPANY, GRIFOLS S.A., WOULD MAINTAIN ITS LISTING IN SPAIN AND WOULD RETAIN CONTROL OF THE U.S. BUSINESS.

GRIFOLS - FOLLOWING THE PROPOSED IPO, THE GRIFOLS’ U.S. BIOPHARMA BUSINESS WILL HAVE ITS OWN BOARD OF DIRECTORS

GRIFOLS -  GROUP WILL CONTINUE TO GROW ITS PLASMA AND DIAGNOSTICS BUSINESSES IN OTHER KEY STRATEGIC MARKETS

GRIFOLS - BOARD HAS APPROVED IPO ON U.S. STOCK MARKET OF A PORTION OF SHARES OF GRIFOLS’ U.S. BIOPHARMA BUSINESS

GRIFOLS: GRIFOLS TO MAINTAIN MAJORITY OWNERSHIP OF ITS U.S. BIOPHARMA BUSINESS

Source text: [ID:]

Further company coverage: GRLS.MC

 ((Reuters.Briefs@thomsonreuters.com;))